M Beliveau Selected Research

(4- ((1- (3- fluorophenyl)methyl)- 1H- indazol- 5- ylamino)- 5- methylpyrrolo(2,1- f)(1,2,4)triazin- 6- yl)carbamic acid 3-morpholinylmethyl ester

1/2019	Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.
2/2012	Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Beliveau Research Topics

Disease

3	Neoplasms (Cancer) 01/2019 - 02/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Anorexia 02/2012
1	Asthenia 02/2012
1	Diarrhea 02/2012
1	Exanthema (Rash) 02/2012
1	Inborn Urea Cycle Disorders 08/2011

Drug/Important Bio-Agent (IBA)

2	(4- ((1- (3- fluorophenyl)methyl)- 1H- indazol- 5- ylamino)- 5- methylpyrrolo(2,1- f)(1,2,4)triazin- 6- yl)carbamic acid 3-morpholinylmethyl esterIBA 01/2019 - 02/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 02/2012
2	Pharmaceutical PreparationsIBA 02/2012 - 08/2011
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	beta-GlucansIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	BTH1677IBA 01/2017
1	Prostaglandins GIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	ErbB Receptors (EGF Receptor)IBA 02/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Investigational DrugsIBA 08/2011
1	AmmoniaIBA 08/2011
1	glycerol phenylbutyrateIBA 08/2011
1	4-phenylbutyric acid (Buphenyl)FDA Link 08/2011

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017
1	Therapeutics 01/2017
1	Aftercare (After-Treatment) 02/2012